Editor’s response: Go back and read the article snippet I wrote on IDGI again before you light up the flamethrower and point it in my direction – it’s clear your passion has blurred your reason.

Josloff may have indeed revamped Inca, but how would we know that? She’s had ZERO communication with the company’s investors, and there is absolutely no evidence of any activity or success. Even the Inca website barely works…. the only two pages are 2007′s line and 2008′s product line. That doesn’t exactly scream success. Where’s the ‘public’ you’re talking about?

Also, I never said the company was pumping with PRs… I said traders are pumping (and bashing) with comments on the message boards. Here’s the quote - ” What’s going on here is an amazing pumping and bashing war, which the pumpers have clearly been winning of late. Even if you never look at them, check out the message boards for this penny stock. You’ll find some really well-reasoned arguments for and against Inca. Some of them may even be based on facts.” 

The company may well be lighting up the fashion world. That’s not my concern. I only care about the stock from an investor’s perspective, where the company’s been doing poorly in terms of publicity. That’s a fact.

Are the pumpers going hog wild with IDGI? Yes they are. That’s a fact. Go here if you don’t believe it: http://messages.finance.yahoo.com/mb/IDGI.PK

Was the company a fuly reporting company through October of last year, and then they chose to stop their SEC filings? Yes. That’s a fact.
Is there more to the story? Yes there is. There always is. Inca may well be the second coming. I only work with facts that I can see and prove though, and I care less about a great looking swimsuit and more about a great looking income statement….. which we haven’t seen yet. That’s a fact too.

In the meantime, IDGI was overbought, and an exit opportunity at the time.

Your desperation is shining through in your words.

Pretty clear you want cheapies by comments like “Friday’s burst, I’d be inclined to try and ride a selloff lower.”

Pathetic!

Editor’s response: I get about 100 unsolicited stock suggestions a week, most of which are from pumpers. Sorry if your feelings got hurt because we didn’t do anything with yours. Just for the record though, we get ideas that are a lot better than yours, and a lot worse.
That said, I probably wouldn’t have touched it anyway. It’s a non-reporting pink sheet company. As such, there’s no real way of verifying anything the company’s got going on fiscally. I don’t invest in great looking swimwear…. I invest in stocks.

As for the ‘cheapies’, I’m not sure what you meant. I’m trying to make money, if not on the long side, then on the short side. Not sure what that’s got to do with ‘cheapies’.

Editor’s response: You’re right – my bad. It wasn’t the FDA that delayed it.

Just for the purpose of knowledge-sharing though, the official CTIC request to the FDA for pixantrone’s approval only came in late June. We were led to believe – by the company – it would be filed long ago (Q1). This will push the approval date back towards the end of the year, at best.

Actually, a fast-track status might get the date pushed up a bit. It’s not going to happen within a few days from now though. We’ve got time to relax.